• Contact
  • Home
  • About
  • Science
    • Publications
  • Pipeline
  • UBX1325
  • Clinical Trials
  • Investors & Media
    • Corporate Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Investor Resources
  • Contact
  • Menu Menu

Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy

January 1, 2016/in Publications/by David Anderson

https://www.ncbi.nlm.nih.gov/pubmed/27797960

Tags: Ophthalmology
https://unitybiotechnology.com//wp-content/uploads/logo.svg 0 0 David Anderson https://unitybiotechnology.com//wp-content/uploads/logo.svg David Anderson2016-01-01 08:00:352024-06-21 14:05:49Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy
You might also like
Cellular Senescence Is Associated With Human Retinal Microaneurysm Formation During Aging
Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy
Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema
UBX1325, a small molecule inhibitor of Bcl-xL, attenuates vascular dysfunction in two animal models of retinopathy
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition
Cellular Senescence Is Associated With Human Retinal Microaneurysm Formation During Aging

©2025 Unity Biotechnology. All Rights Reserved. Terms & Conditions | Privacy Policy

Naturally occurring p16Ink4a-positive cells shorten healthy lifespanClearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells...
Scroll to top